MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17434440.2026.2746135

Медицинская библиотека · Expert review of medical devices · 2026

Safety and efficacy of indigenous ultrathin-strut versus international thin-strut drug-eluting coronary stents in percutaneous coronary intervention: a systematic review of randomized controlled trials.

Bhosale Ashutosh, Pratima Pandey, Sinha Anit Kumar, Karattuthodi Mohammed Salim, Gangachannaiah Shivaprakash, Thunga Girish, Kumar Basant, Ramachandran Padmakumar, Kalaiselvan Vivekanandan, Shelke Akshay, Murti Krishna, Radhakrishnan Rajesh

СтатьяОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

Ultrathin-strut drug-eluting stents (DES) have been developed to enhance vascular healing and reduce restenosis following percutaneous coronary intervention (PCI). Indigenous biodegradable-polymer ultrathin-strut DES are increasingly used in high-burden settings; however, comparative evidence against internationally established thin-strut DES remains limited.

METHODS

This systematic review of randomized controlled trials was conducted according to PRISMA 2020 guidelines. PubMed, Embase, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials were searched from inception to December 2025. Trials comparing indigenous ultrathin-strut DES with internationally manufactured thin-strut DES in adult PCI populations were included. Primary outcomes were major adverse cardiac events/trial-defined composite endpoints. Secondary outcomes included myocardial infarction, target lesion and vessel revascularization, stent thrombosis, cardiac death, and all-cause mortality. Risk of bias was assessed using the Cochrane RoB-2 tool, and a narrative synthesis was performed.

RESULTS

Four randomized trials including 2,793 patients were analyzed. Indigenous stents demonstrated comparable rates of composite endpoints, myocardial infarction, repeat revascularization, and stent thrombosis across studies, with no consistent differences between groups.

CONCLUSION

The available RCT evidence shows no consistent signal of superiority or inferiority between indigenous and international thin-strut DES. However, heterogeneity and limited trial numbers warrant larger studies with long-term follow-up and real-world materiovigilance.

Для цитирования: Bhosale Ashutosh, Pratima Pandey, Sinha Anit Kumar, Karattuthodi Mohammed Salim, Gangachannaiah Shivaprakash, Thunga Girish, Kumar Basant, Ramachandran Padmakumar, Kalaiselvan Vivekanandan, Shelke Akshay, Murti Krishna, Radhakrishnan Rajesh. Safety and efficacy of indigenous ultrathin-strut versus international thin-strut drug-eluting coronary stents in percutaneous coronary intervention: a systematic review of randomized controlled trials.. Expert review of medical devices. 2026. DOI: 10.1080/17434440.2026.2746135.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.